TAHO Pharmaceuticals LtdTT

TAHO Pharmaceuticals Ltd

168.5TWDR
−5.0−2.88%
At close at Nov 14, 06:59 GMT
TWD
No trades
See on Supercharts
Market capitalization
‪8.77 B‬TWD
−3.5TWD
‪−167.44 M‬TWD
0.00TWD
‪15.54 M‬
Beta (1Y)
−12.96

About TAHO Pharmaceuticals Ltd


CEO
Howard Lee
Headquarters
Taipei
ISIN
TW0006467004
FIGI
BBG006XXYMC8
Taho Pharmaceuticals Ltd. engages in the research and development of pharmaceutical products. Its Technology Platform products are the Transepithelial Delivery System, Transdermal DDS, Transmucosal SSD, and Bio-Revie. The firm's Research & Development products include medicines for migraine, alzheimer's disease, hyperactivity disorder, and nausea caused by chemotherapy. The company was founded on July 7, 2010 and is headquartered in Taipei, Taiwan.
Performance
‪−2,400.0%‬
‪−2,000.0%‬
‪−1,600.0%‬
‪−1,200.0%‬
‪−800.0%‬
H1 '18
H1 '23
H1 '24
H2 '24
H1 '25
‪‪−105.00 M‬‬
‪‪−70.00 M‬‬
‪‪−35.00 M‬‬
‪0.00‬
‪‪35.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−78.00 M‬‬
‪‪−52.00 M‬‬
‪‪−26.00 M‬‬
‪0.00‬
‪‪26.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−75.00 M‬‬
‪‪−50.00 M‬‬
‪‪−25.00 M‬‬
‪0.00‬
‪‪25.00 M‬‬
Debt level and coverage
H1 '18
H1 '23
H1 '24
H2 '24
H1 '25
‪‪−100.00 M‬‬
‪0.00‬
‪‪100.00 M‬‬
‪‪200.00 M‬‬
‪‪300.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6467 is 168.5 TWD — it has decreased by −2.88% in the past 24 hours. Watch TAHO Pharmaceuticals Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange TAHO Pharmaceuticals Ltd stocks are traded under the ticker 6467.
6467 stock has fallen by −4.26% compared to the previous week, the month change is a 1.00% rise, over the last year TAHO Pharmaceuticals Ltd has showed a 151.75% increase.
6467 reached its all-time high on Sep 4, 2025 with the price of 208.5 TWD, and its all-time low was 32.0 TWD and was reached on Dec 30, 2024. View more price dynamics on 6467 chart.
See other stocks reaching their highest and lowest prices.
6467 stock is 4.52% volatile and has beta coefficient of −13.22. Track TAHO Pharmaceuticals Ltd stock price on the chart and check out the list of the most volatile stocks — is TAHO Pharmaceuticals Ltd there?
Today TAHO Pharmaceuticals Ltd has the market capitalization of ‪8.77 B‬, it has decreased by −2.22% over the last week.
Yes, you can track TAHO Pharmaceuticals Ltd financials in yearly and quarterly reports right on TradingView.
6467 net income for the last half-year is ‪−71.90 M‬ TWD, while the previous report showed ‪−94.07 M‬ TWD of net income which accounts for 23.57% change. Track more TAHO Pharmaceuticals Ltd financial stats to get the full picture.
No, 6467 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6467 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TAHO Pharmaceuticals Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TAHO Pharmaceuticals Ltd technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TAHO Pharmaceuticals Ltd stock shows the sell signal. See more of TAHO Pharmaceuticals Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.